KATIE FOLKENROTH: Open Payments
NPI 1437936390 · MECHANICSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,916 in 93 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $2,060 · 2025 $1,916
Food & beverage: $1,759Education: $157
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $347 |
| ABBVIE INC. | 17 | $317 |
| Galderma Laboratories, L.P. | 16 | $289 |
| Janssen Biotech, Inc. | 8 | $200 |
| Novartis Pharmaceuticals Corporation | 13 | $166 |
| Amgen Inc. | 9 | $158 |
| Lilly USA, LLC | 5 | $112 |
| E.R. Squibb & Sons, L.L.C. | 3 | $74 |
| UCB, Inc. | 3 | $64 |
| LEO Pharma Inc. | 2 | $47 |
Products named: RINVOQ, NEMLUVIO, TREMFYA, ILUMYA, COSENTYX, OTEZLA, SKYRIZI, DUPIXENT.
Industry payments across PA — which companies pay providers there.
